Page 7 - Lympro Test News Today

DGAP-News: Todos Medical, Ltd / Key word(s): Agreement24.11.2021 / 08:00 The issuer is solely responsible for the content of this announcement.Todos Medical Announces Exclusive License & Distribution Agreement with T-Cell Protect Hellas S.A. for Tollovid(R) Products Covering 30 Countries in Europe- The agreement...

·       T-Cell Protect is also evaluating expected demand for maximum strength Tollovid® New York, NY, and Tel Aviv, ISRAEL, Nov. 22, 2021 (GLOBE...

Press release content from NewMediaWire. The AP news staff was not involved in its creation.

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

GuruFocus Article or News written by Marketwired and the topic is about:

Dr. Jorge Leone, Chief Scientific Officer of Todos Medical, and Sean Taylor, North American FAS Manager of Genscript, will discuss the importance of...

Accurate Diagnostic Solutions Remain Vital to Overcoming the Pandemic News provided by Share this article - FinancialBuzz.com News Commentary NEW YORK, May 4, 2021 /PRNewswire/ -- While the U.S and the rest of the Western world is slowly recovering from the worst phases of the pandemic, India is going through its worst wave yet. In 24 hours, the country reported more than 368,000 news cases, bringing the total number of cases to more than 19 million, while the total number of deaths is more tha...

Press release content from NewMediaWire. The AP news staff was not involved in its creation. Todos Medical Receives FDA Certificate of Free Sale for New 5-Day Tollovid Dosing Regimen Todos Medical, LtdMay 4, 2021 GMT Company sees this new dosing regimen of 60 pills over 5 days as optimal for Tollovid, the Company’s 3CL protease inhibitor botanical dietary supplement that helps to support and maintain healthy immune function New York, NY - ( NewMediaWire ) - May 04, 2021 - Todos Medical, Ltd. ...

Posted on 5153 Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that the US Food & Drug Administration granted the Company a new Certificate of Free Sale for a second dosing regimen for Tollovid™ as a dietary supplement. Under the new Certificate of Free Sale, the Company is authorized to market Tollovid with a dosing regimen of 60 pills over a five-day period, ...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Todos Medical Acquires Provista Diagnostics and Its Proprietary Videssa Breast Cancer Blood Test Todos Medical Ltd.April 22, 2021 GMT   Todos plans to commercialize Videssa in late 2021 to reduce unnecessary biopsies in the $7.19 billion mammogram naïve market and integrate it into its TBIA Platform   Provista Diagnostics’ testing lab in the Atlanta, Georgia area is currently performing COVID-1...